Even 'low-dose' cabazitaxel requires careful and meticulous patient selection

被引：2
作者：
Heidenreich, Axel [1 ]
Pfister, David [1 ]
机构：
[1] Univ Cologne, Dept Urol Urooncol Robot Assisted & Reconstruct U, Cologne, Germany
来源：
BJU INTERNATIONAL | 2018年 / 121卷 / 02期
关键词：
COMPASSIONATE-USE PROGRAM; PROSTATE-CANCER; MANAGEMENT;
D O I：
10.1111/bju.13879
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 6 条
[1]   Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer [J].
Clement-Zhao, Alice ;
Auvray, Marie ;
Aboudagga, Hail ;
Blanc-Durand, Elix ;
Angelergues, Antoine ;
Vano, Yann Alexandre ;
Mercier, Florence ;
El Awadly, Nader ;
Verret, Benjamin ;
Thibault, Constance ;
Oudard, Stephane .
BJU INTERNATIONAL, 2018, 121 (02) :203-208
[2]   Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology [J].
Droz, Jean-Pierre ;
Aapro, Matti ;
Balducci, Lodovico ;
Boyle, Helen ;
Van den Broeck, Thomas ;
Cathcart, Paul ;
Dickinson, Louise ;
Efstathiou, Eleni ;
Emberton, Mark ;
Fitzpatrick, John M. ;
Heidenreich, Axel ;
Hughes, Simon ;
Joniau, Steven ;
Kattan, Michael ;
Mottet, Nicolas ;
Oudard, Stephane ;
Payne, Heather ;
Saad, Fred ;
Sugihara, Toru .
LANCET ONCOLOGY, 2014, 15 (09) :E404-E414
[3]   Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel [J].
Fitzpatrick, John M. ;
Bellmunt, Joaquim ;
Fizazi, Karim ;
Heidenreich, Axel ;
Sternberg, Cora N. ;
Tombal, Bertrand ;
Alcaraz, Antonio ;
Bahl, Amit ;
Bracarda, Sergio ;
Di Lorenzo, Giuseppe ;
Efstathiou, Eleni ;
Finn, Stephen P. ;
Fossa, Sophie ;
Gillessen, Silke ;
Kellokumpu-Lehtinen, Pirkko-Liisa ;
Lecouvet, Frederic E. ;
Oudard, Stephane ;
de Reijke, Theo M. ;
Robson, Craig N. ;
De Santis, Maria ;
Seruga, Bostjan ;
de Wit, Ronald .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (09) :1617-1627
[4]   Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme [J].
Heidenreich, Axel ;
Bracarda, Sergio ;
Mason, Malcolm ;
Ozen, Haluk ;
Sengelov, Lisa ;
Van Oort, Inge ;
Papandreou, Christos ;
Fossa, Sophie ;
Hitier, Simon ;
Angel Climent, Miguel .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (06) :1090-1099
[5]   Cabazitaxel Plus Prednisone for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel: Results from the German Compassionate-use Programme [J].
Heidenreich, Axel ;
Scholz, Hans-Joerg ;
Rogenhofer, Sebastian ;
Arsov, Christian ;
Retz, Margitta ;
Mueller, Stefan C. ;
Albers, Peter ;
Gschwend, Juergen ;
Wirth, Manfred ;
Steiner, Ursula ;
Miller, Kurt ;
Heinrich, Elmar ;
Trojan, Lutz ;
Volkmer, Bjoern ;
Honecker, Friedhelm ;
Bokemeyer, Carsten ;
Trojan, Lutz ;
Volkmer, Bjoern ;
Honecker, Friedhelm ;
Bokemeyer, Carsten ;
Keck, Bastian ;
Otremba, Burkhard ;
Ecstein-Fraisse, Evelyne ;
Pfister, David .
EUROPEAN UROLOGY, 2013, 63 (06) :977-982
[6]   Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial [J].
Meisel, Alexander ;
von Felten, Stefanie ;
Vogt, Deborah R. ;
Liewen, Heike ;
de Wit, Ronald ;
de Bono, Johann ;
Sartor, Oliver ;
Stenner-Liewen, Frank .
EUROPEAN JOURNAL OF CANCER, 2016, 56 :93-100
1